Contact
Please use this form to send email to PR contact of this press release:
FDA Approves New Indication for IMBRUVICA(™) (ibrutinib), Distributed by Avella
TO:
Please use this form to send email to PR contact of this press release:
FDA Approves New Indication for IMBRUVICA(™) (ibrutinib), Distributed by Avella
TO: